18 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am
and fulfils commitment to promote female leadership in biotech
VANCOUVER, Nov. 06, 2018 /CNW/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP … is also an example of RepliCel's commitment to fulfill its part in the industry's promise to promote female leadership in the industry."
Dr. Goessens
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
29 Aug 23
RepliCel announces the passing of long time Chief Financial Officer Simon Ma; David Kwok is appointed Chief Financial Officer
1:14pm
on our team and his legacy of integrity and leadership will continue to inspire us.” President & CEO Andrew Schutte stated.
David Kwok steps
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
7 Oct 14
RepliCel Life Sciences Adds Industry Specialist to Management Team
12:00am
a significant opportunity to establish a leadership role in the regenerative medicine sector."
“We are delighted to have Lee join the RepliCel team
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
of Victoria Centre for Biomedical Engineering, Laboratory for Innovations in Microengineering under the leadership of Dr. Mohsen Akbari with input from
6-K
REPCF
Replicel Life Sciences Inc.
13 Jun 11
Current report (foreign)
12:00am
Wayrynen as director effective May 27, 2011. The Board would like to thank Mr. Wayrynen for the valuable insight and leadership he provided during his
6-K
EX-99.1
e6zvbn409ynbe3y
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.1
cturos u0df8ex93
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
20-F/A
dnb0wdmcslw
12 Jan 18
Annual report (foreign) (amended)
12:00am
- Prev
- 1
- Next